Intrathecal substance p-saporin in the dog efficacy in bone cancer pain

Anesthesiology

Volumn 119, Issue 5, 2013, Pages 1178-1185

  Brown, Dorothy Cimino ^a   Agnello, Kimberly ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINOCICEPTIVE AGENT; CORTICOSTEROID; GABAPENTIN; NONSTEROID ANTIINFLAMMATORY AGENT; SAPORIN; SUBSTANCE P; SUBSTANCE P SAPORIN; TRAMADOL; UNCLASSIFIED DRUG;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EUTHANASIA; ANIMAL LAMENESS; ANTINOCICEPTION; ARTICLE; ATAXIA; BONE CANCER; CANCER PAIN; CHRONIC PAIN; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EXPERIMENTAL DOG; FEMALE; INTRALUMBAR DRUG ADMINISTRATION; LIMB WEAKNESS; MALE; NONHUMAN; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT DURATION; VIDEORECORDING;

ANIMALS; BEHAVIOR, ANIMAL; BONE NEOPLASMS; DOG DISEASES; DOGS; DOUBLE-BLIND METHOD; INJECTIONS, SPINAL; LAMENESS, ANIMAL; MOTOR ACTIVITY; PAIN MEASUREMENT; PAIN, INTRACTABLE; PROSPECTIVE STUDIES; RIBOSOME INACTIVATING PROTEINS, TYPE 1; SUBSTANCE P; TREATMENT OUTCOME;

EID: 84888216897     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3182a95188     Document Type: Article

References (31)

1. Honore P, Mantyh PW: Bone cancer pain: From mechanism to model to therapy. Pain Med 2000; 1:303-9
2. Brescia FJ, Portenoy RK, Ryan M, Krasnoff L, Gray G: Pain, opioid use, and survival in hospitalized patients with advanced cancer. J Clin Oncol 1992; 10:149-55
3. Mueller F, Fuchs B, Kaser-Hotz B: Comparative biology of human and canine osteosarcoma. Anticancer Res 2007; 27(1A):155-64
4. Withrow SJ, Powers BE, Straw RC, Wilkins RM: Comparative aspects of osteosarcoma. Dog versus man. Clin Orthop Relat Res 1991; 270:159-68
5. MacEwen EG: Spontaneous tumors in dogs and cats: Models for the study of cancer biology and treatment. Cancer Metastasis Rev 1990; 9:125-36
6. Brown DC, Boston R, Coyne JC, Farrar JT: A novel approach to the use of animals in studies of pain: Validation of the canine brief pain inventory in canine bone cancer. Pain Med 2009; 10:133-42
7. Brown DC, Iadarola MJ, Perkowski SZ, Erin H, Shofer F, Laszlo KJ, Olah Z, Mannes AJ: Physiologic and antinociceptive effects of intrathecal resiniferatoxin in a canine bone cancer model. Anesthesiolog y 2005; 103:1052-9
8. Karai L, Brown DC, Mannes AJ, Connelly ST, Brown J, Gandal M, Wellisch OM, Neubert JK, Olah Z, Iadarola MJ: Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control. J Clin Invest 2004; 113:1344-52
9. Mantyh PW: A mechanism based understanding of cancer pain. Pain 2002; 96:1-2
10. Medhurst SJ, Walker K, Bowes M, Kidd BL, Glatt M, Muller M, Hattenberger M, Vaxelaire J, O'Reilly T, Wotherspoon G, Winter J, Green J, Urban L: A rat model of bone cancer pain. Pain 2002; 96:129-40
11. Schwei MJ, Honore P, Rogers SD, Salak-Johnson JL, Finke MP, Ramnaraine ML, Clohisy DR, Mantyh PW: Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci 1999; 19:10886-97
12. Menéndez L, Juárez L, García E, García- Suárez O, Hidalgo A, Baamonde A: Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice. Neurosci Lett 2006; 393:70-3
13. Vermeirsch H, Nuydens RM, Salmon PL, Meert TF: Bone cancer pain model in mice: Evaluation of pain behavior, bone destruction and morphine sensitivity. Pharmacol Biochem Behav 2004; 79:243-51
14. Wiese A, Rathbun M, Richter P, Osbourne K, Xu Q, Veeshart S, Steinauer J, Higgins D, Lappi D, Russell B, Yaksh T: Intrathecal substance P-saporin in the dog: Distribution, safety, and spinal neurokinin-1 receptor ablation. Anesthesiolog y 2013; 119:1163-77
15. Brown DC, Boston RC, Farrar JT: Use of an activity monitor to detect response to treatment in dogs with osteoarthritis. J Am Vet Med Assoc 2010; 237:66-70
16. Doig GS, Simpson F: Randomization and allocation concealment: A practical guide for researchers. J Crit Care 2005; 20:187-91; discussion 191-3
17. Allen JW, Mantyh PW, Horais K, Tozier N, Rogers SD, Ghilardi JR, Cizkova D, Grafe MR, Richter P, Lappi DA, Yaksh TL: Safety evaluation of intrathecal substance P-saporin, a targeted neurotoxin, in dogs. Toxicol Sci 2006; 91:286-98
18. Brown DC, Boston RC, Coyne JC, Farrar JT: Development and psychometric testing of an instrument designed to measure chronic pain in dogs with osteoarthritis. Am J Vet Res 2007; 68:631-7
19. Dow C, Michel KE, Love M, Brown DC: Evaluation of optimal sampling interval for activity monitoring in companion dogs. Am J Vet Res 2009; 70:444-8
20. Brown DC: Sources and handling of losses to follow-up in parallel-group randomized clinical trials in dogs and cats: 63 trials (2000-2005). Am J Vet Res 2007; 68:694-8
21. Ostrander EA, Galibert F, Patterson DF: Canine genetics comes of age. Trends Genet 2000; 16:117-24
22. Vail DM, MacEwen EG: Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest 2000; 18:781-92
23. Mao J: Translational pain research: Bridging the gap between basic and clinical research. Pain 2002; 97:183-7
24. Y aksh TL: Spinal delivery and assessment of drug safety, Fundamental Neuropathology for Pathologists and Toxicologists: Principles and Techniques, Ist edition. Edited by Bolon B, Butt M. New York, Wiley & Sons, 2011, pp 451-62
25. Mantyh PW, Rogers SD, Honore P, Allen BJ, Ghilardi JR, Li J, Daughters RS, Lappi DA, Wiley RG, Simone DA: Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science 1997; 278:275-9
26. Quartara L, Maggi CA: The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles. Neuropeptides 1998; 32:1-49
27. Kríz N, Yamamotová A, Tobiás J, Rokyta R: Tail-flick latency and self-mutilation following unilateral deafferentation in rats. Physiol Res 2006; 55:213-20
28. Kríz N, Rokyta R: Effect of unilateral deafferentation on extracellular potassium concentration levels in rat thalamic nuclei. Neuroscience 2000; 96:101-8
29. Albe-Fessard D, Rampin O: Neurophysical studies in rats deafferented by dorsal root sections, Deafferentation Pain Syndromes: Pathophysiology and Treatments. Edited by Nashold B, Ovelmen-Levitt J. New York, Raven Press, 1991, pp 125-39
30. Khasabov SG, Rogers SD, Ghilardi JR, Peters CM, Mantyh PW, Simone DA: Spinal neurons that possess the substance P receptor are required for the development of central sensitization. J Neurosci 2002; 22:9086-98
31. Choi JI, Koehrn FJ, Sorkin LS: Carrageenan induced phosphorylation of Akt is dependent on neurokinin-1 expressing neurons in the superficial dorsal horn. Mol Pain 2012; 8:4